Nisin inhibits several gram-positive, mastitis-causing pathogens.

Area of Science:

• Veterinary Microbiology
• Antimicrobial Peptides
• Bovine Health

Background:

• Bovine mastitis is a significant economic concern in the dairy industry, often caused by Gram-positive bacteria.
• Controlling mastitis-causing pathogens is crucial for animal welfare and milk production.
• Nisin, a bacteriocin produced by lactic acid bacteria, shows potential as a natural antimicrobial agent.

Purpose of the Study:

• To evaluate the susceptibility of key bovine mastitis pathogens to the antimicrobial peptide nisin.
• To determine the minimum inhibitory concentrations (MICs) of nisin against selected bacterial strains.
• To assess the efficacy of nisin in inhibiting these pathogens in a milk matrix.

Main Methods:

• Bacterial strains including Enterococcus faecalis, Staphylococcus aureus, Streptococcus agalactiae, Streptococcus equinus, Streptococcus dysgalactiae, Streptococcus uberis, and Staphylococcus epidermidis were used.
• A disc diffusion assay was employed to determine nisin susceptibility.
• Minimum inhibitory concentrations (MICs) were quantified.
• The antimicrobial effect of 50 µg/ml nisin was tested in bovine milk.

Main Results:

• Nisin demonstrated varying minimum inhibitory concentrations (MICs) against the tested mastitis pathogens, ranging from 10 to 250 µg/ml.
• A concentration of 50 µg/ml nisin effectively inhibited all Gram-positive bacterial strains tested in bovine milk.
• The study confirmed nisin's broad-spectrum activity against common bovine mastitis-causing bacteria.

Conclusions:

• Nisin exhibits significant antimicrobial activity against a range of Gram-positive bacteria responsible for bovine mastitis.
• Nisin shows promise as a potential therapeutic or preventative agent for bovine mastitis.
• Further research into nisin's application in dairy farming could lead to improved mastitis control strategies.